论文部分内容阅读
目的:分析茵栀黄颗粒治疗ABO血型不合的临床效果。方法:对我院2014年4月至2015年4月收治的58例ABO母婴血型不合的孕妇实行有效观察,其中29例对照组采用常规西药治疗,29例研究组采用常规治疗的同时增加茵栀黄颗粒治疗,并对比两组的临床疗效。结果:研究组的中医症候积分少于对照组,P<0.05;中医症候和整体治疗的治疗总有效率均优于对照组,P<0.05;不良妊娠结局发生率少于对照组,P<0.05。结论:茵栀黄颗粒治疗ABO血型不合具有较高临床治疗效果,能够有效改善孕妇的分娩结局,减少新生儿出现黄疸的几率,值得推广。
Objective: To analyze the clinical effect of Yinzhihuang granule in treating ABO blood group incompatibility. Methods: Fifty-eight pregnant women with ABO maternal-fetal incommensurability were treated in our hospital from April 2014 to April 2015, 29 of them were treated with conventional western medicine, while 29 of them were treated with conventional treatment Zhizhuang granules treatment, and compared the clinical efficacy of the two groups. Results: The TCM symptom score of the study group was less than that of the control group, P <0.05; the total effective rate of TCM symptoms and overall treatment was better than that of the control group (P <0.05); the incidence of adverse pregnancy outcome was less than that of the control group (P <0.05) . Conclusion: Yinzhihuang Granules can effectively improve the delivery outcome of pregnant women and reduce the incidence of jaundice in neonates, which is worthy of popularization.